Apellis Stock Valuation

APLS
 Stock
  

USD 49.13  1.23  2.44%   

How much is Apellis Pharmaceuticals worth today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Apellis Pharmaceuticals, is its stock price multiplied by the total number of shares outstanding, calculating Apellis Pharmaceuticals' enterprise value requires a different approach. It uses Apellis Pharmaceuticals' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
As of 12/10/2022, Tangible Asset Value is likely to grow to about 951.4 M, while Free Cash Flow is likely to drop (579.1 M).
Apellis Pharmaceuticals shows a prevailing Real Value of $56.36 per share. The current price of the firm is $49.13. At this time, the firm appears to be undervalued. Our model approximates the value of Apellis Pharmaceuticals from analyzing the firm fundamentals such as operating margin of (4.60) %, and Return On Equity of (5.07) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Apellis Pharmaceuticals Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Apellis Pharmaceuticals's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Apellis Most Recent Valuation Data

Beta
1.1688
Fiscal Year End
December
Property Plant And Equipment Net
26.1 M
Enterprise Value
B
Net Debt
-430 M
Accounts Payable
16.9 M
Undervalued
Today 49.13
Please note that Apellis Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Apellis Pharmaceuticals is based on 3 months time horizon. Increasing Apellis Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Apellis Pharmaceuticals is useful when determining the fair value of the Apellis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Apellis Pharmaceuticals. Since Apellis Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Apellis Stock. However, Apellis Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
56.36
Real Value
60.58
Upside
Estimating the potential upside or downside of Apellis Pharmaceuticals helps investors to forecast how Apellis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Apellis Pharmaceuticals more accurately as focusing exclusively on Apellis Pharmaceuticals' fundamentals will not take into account other important factors:
Earnings
Estimates (9)
LowProjected EPSHigh
-8.83-8.45-7.59
Details
Hype
Prediction
LowEstimated ValueHigh
42.6646.8851.10
Details
Naive
Forecast
LowNext ValueHigh
45.2849.5053.71
Details
13 Analysts
Consensus
LowTarget PriceHigh
28.0069.14112.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Apellis Pharmaceuticals' intrinsic value based on its ongoing forecasts of Apellis Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Apellis Pharmaceuticals' closest peers. When choosing an evaluation method for Apellis Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Apellis Valuation Drivers Correlation

Many accounts on the financial statements of Apellis Pharmaceuticals are highly interrelated and sometimes correlated. Consequently, when conducting Apellis's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Apellis
Click cells to compare fundamentals

Apellis Valuation Trend

Knowing Apellis Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Apellis Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Apellis Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Apellis Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Apellis Market Cap

Apellis Pharmaceuticals is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 38.6 Billion. Apellis Pharmaceuticals retains roughly 5.57 Billion in market capitalization claiming about 14% of equities under Health Care industry.
Capitalization  Total debt  Revenue  Valuation  Workforce

Apellis Pharmaceuticals Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Apellis Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Apellis Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apellis Pharmaceuticals competition to find correlations between indicators driving Apellis Pharmaceuticals's intrinsic value. More Info.
Apellis Pharmaceuticals is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies . As of 12/10/2022, Price to Book Value is likely to grow to 23.79. Comparative valuation analysis is a catch-all model that can be used if you cannot value Apellis Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Apellis Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apellis Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Apellis Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Apellis Pharmaceuticals and how it compares across the competition.

About Apellis Pharmaceuticals Valuation

The stock valuation mechanism determines the current worth of Apellis Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Apellis Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Apellis Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Apellis Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Apellis Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Apellis Pharmaceuticals. We calculate exposure to Apellis Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Apellis Pharmaceuticals's related companies.
Fiscal Year End
December
Industry
Biotechnology
Concentration
Biotechnology
Full Time Employees
476
Service Category
Biotechnology
Employer Id Number
27-1537290
Last ReportedProjected for 2022
Gross Profit66.4 M101.7 M

Apellis Pharmaceuticals Current Valuation Indicators

Valuation refers to the process of determining the present value of Apellis Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Apellis we look at many different elements of the entity such as Apellis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Apellis Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Apellis Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Apellis Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Apellis Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Apellis Pharmaceuticals' worth.
Please continue to Trending Equities. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for analysis

When running Apellis Pharmaceuticals price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Is Apellis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apellis Pharmaceuticals. If investors know Apellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apellis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
5.6 B
Quarterly Revenue Growth YOY
2.904
Return On Assets
(0.46) 
Return On Equity
(5.07) 
The market value of Apellis Pharmaceuticals is measured differently than its book value, which is the value of Apellis that is recorded on the company's balance sheet. Investors also form their own opinion of Apellis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Apellis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apellis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Apellis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apellis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Apellis Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apellis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.